Eric Dube (he/him)

Eric Dube (he/him) has had a long and varied career in the pharmaceutical industry. Eric began in 2008 as SVP, Strategy, Planning & Operations, US Pharmaceuticals, and Vice President, Oncology Business Unit Head at GlaxoSmithKline. In 2013, they moved to GlaxoSmithKline Japan as VP & Corporate Officer, Respiratory Business Unit Head. In 2015, they returned to GSK as SVP and Head, Global Respiratory Franchise. In 2018, they became Head, ViiV North America at ViiV Healthcare. In 2019, they became CEO of Travere Therapeutics, and in 2021 they took on the role of Independent Director at Reneo Pharmaceuticals.

Eric Dube (he/him) completed their PhD in Developmental & Social Psychology from Cornell University between 1995 and 1999. Eric then went on to obtain a BS in Biopsychology from Santa Clara University between 1991 and 1994. In 2012, they attended Harvard Business School for Finance and Financial Management Services, but did not obtain a degree.